Study details
Enrolling now
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
Evon Medics LLC
NCT IDNCT06434818ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
300
Study length
about 2 years
Ages
18–80
Locations
3 sites in DC, MD
What this study is about
This trial is testing a new device called EDITOR to help people manage substance use disorders. It involves using digital and chemosensory training, along with remote monitoring. The goal is to see if this device helps people stay in treatment and avoid using substances.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CBOT Sham
- 2.Take CBOT with olfactory stimulants & OFC tasks
- 3.Use EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health